Log in to save to my catalogue

Determinants of transthyretin levels and their association with adverse clinical outcomes among UK B...

Determinants of transthyretin levels and their association with adverse clinical outcomes among UK B...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4a038558f52b4717a5f4e080197ae2aa

Determinants of transthyretin levels and their association with adverse clinical outcomes among UK Biobank participants

About this item

Full title

Determinants of transthyretin levels and their association with adverse clinical outcomes among UK Biobank participants

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2024-07, Vol.15 (1), p.6221-7, Article 6221

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Transthyretin is a transport protein whose misfolding has been implicated in the development of cardiac amyloidosis. Here, we examine the clinical correlates of transthyretin levels, the differences in transthyretin levels according to the pathogenic V142I
TTR
variant carrier status, and the association of transthyretin levels with outcomes a...

Alternative Titles

Full title

Determinants of transthyretin levels and their association with adverse clinical outcomes among UK Biobank participants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4a038558f52b4717a5f4e080197ae2aa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4a038558f52b4717a5f4e080197ae2aa

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-50231-1

How to access this item